All Clinical Resources

49 - 60 of 235 results

Easy Management of Statin Induced Myalgias - Frankly Speaking EP4

Have a patient with Statin Induced Myalgias? This episode will give you the best evidence on a simple and cost effective solution, and dispel common myths about this problem. Guest: Robert A. Baldor, MD, FAAFP

Have a patient with Statin Induced Myalgias? This episode will give you the best evidence on a simple and cost effective solution, and dispel common myths about this problem.


FAQ for ADD & ADHD in Children and Adults: Beyond Stimulants

Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.Guest: Daniel Press, MD

Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.


FAQ for Chronic Pain: 20/20 Vision in 60 Minutes

Guest: Esther M. Benedetti, MD, FIPP


FAQ for Update in the Diagnosis and Management of Stroke and TIA

Guest: Yolanda Reyes-Iglesias, MD, CPE, FAHA


The Continuum of Heart Failure

Industry Webcast Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Not for CME/CE Credit

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.


Cardiovascular Disease Journey. “It’s the Little Things”: A Tale of Two Patients

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This program follows two patients on their cardiovascular disease (CVD) journeys. Risk factors leading to the development and progression of atherosclerotic CVD and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted.


Image of skull and neck with arteries highlighting

Clinical Considerations in Coronary Artery Disease

Industry Webcast Sponsored by AstraZeneca Pharmaceuticals, LP; Not for CME/CE Credit

• Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA). • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial


computer drawing of a heart

Primary Care Heart Failure Learning Module

An Adaptive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

Heart failure (HF) is a complex syndrome brought on by impairment of the structure or function of ventricular filling or blood ejection. These changes can significantly decrease quality of life, resulting in edema, dyspnea, and fatigue. The disease is widespread and progresses in severity, resulting in significant morbidity and mortality. This course is built on the latest HF guidelines and seeks to help learners better understand this prevalent, serious disease. Topics include pathophysiology, etiology, and epidemiology, morbidity and mortality, diagnosis through the use of biomarkers and other screening tools, impact of HF hospitalization, hospitalization care goals and team-based care.


An Evolving Treatment Paradigm for Chronic Heart Failure in Primary Care

Industry Webcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

This program will review recent developments in the treatment of patients with chronic heart failure and discuss the important role of the primary care physician.


Patient holding head while speaking with Doctor

Diagnosing Migraine

An Interactive Learning Experience Sponsored by Amgen and Novartis; Not for CME/CE CreditThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

This “Diagnosing Migraine” module includes didactic and case-based questions to reinforce your knowledge on this topic so you can better diagnose and help your patients.


Case Study: A 51-Year-Old Female With Crohn’s Disease and Intestinal Resection*

Industry Webcast Sponsored by Takeda Pharmaceuticals U.S.A., Inc.; Not for CME/CE Credit